Skip to content
healthcare.dev

Tranexamic Acid

NDC 25021-415, Tranexamic Acid, injection, solution, from Sagent Pharmaceuticals.

Product NDC
25021-415
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207239
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-415 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRANEXAMIC ACID100 mg/mL

Pharmacologic classes

Antifibrinolytic Agent [EPC]; Decreased Fibrinolysis [PE]

Package NDCNDC-11Package
25021-415-102502104151010 VIAL in 1 CARTON (25021-415-10) / 10 mL in 1 VIAL
25021-415-662502104156610 VIAL in 1 CARTON (25021-415-66) / 10 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels?ndc=25021-415
  • NADAC price for package 25021041510

    GET /v1/drugs/nadac/25021041510
  • NADAC price for package 25021041566

    GET /v1/drugs/nadac/25021041566

Use it

Look up 25021-415 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-415 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-415. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.